Nymox Pharmaceutical
NYMX
#8005
Rank
$18.25 M
Marketcap
Bahamas
Country
$0.20
Share price
0.00%
Change (1 day)
-53.49%
Change (1 year)
Categories
Nymox Pharmaceutical (NYMX) - Total assets
Total assets on the balance sheet as of June 2023 : $0.27 M
According to Nymox Pharmaceutical's latest financial reports the company's total assets are $0.27 M. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Nymox Pharmaceutical - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $1.62 M | 12.61% |
| 2021-12-31 | $1.44 M | -66.77% |
| 2020-12-31 | $4.34 M | -20.88% |
| 2019-12-31 | $5.48 M | -32.03% |
| 2018-12-31 | $8.07 M | 724.92% |
| 2017-12-31 | $0.97 M | -52.41% |
| 2016-12-31 | $2.05 M | 188.85% |
| 2015-12-31 | $0.71 M | -49.93% |
| 2014-12-31 | $1.42 M | 47.2% |
| 2013-12-31 | $0.96 M | -44.91% |
| 2012-12-31 | $1.75 M | -72.48% |
| 2011-12-31 | $6.37 M | -52.78% |
| 2010-12-31 | $13.5 M | 1138.25% |
| 2009-12-31 | $1.09 M | -73.19% |
| 2008-12-31 | $4.06 M | -4.52% |
| 2007-12-31 | $4.26 M | 7.29% |
| 2006-12-31 | $3.97 M | 6.77% |
| 2005-12-31 | $3.71 M | -8.53% |
| 2004-12-31 | $4.06 M | -1.37% |
| 2003-12-31 | $4.12 M | -5.42% |
| 2002-12-31 | $4.35 M | 3.97% |
| 2001-12-31 | $4.19 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $167.55 B | 61,829,420.30% | 🇺🇸 USA |
 Pfizer PFE | $226.50 B | 83,579,604.80% | 🇺🇸 USA |
 Abbott Laboratories ABT | $73.21 B | 27,016,136.16% | 🇺🇸 USA |
 Eli Lilly LLY | $64.00 B | 23,618,460.89% | 🇺🇸 USA |
 Quest Diagnostics
DGX | $14.02 B | 5,174,069.74% | 🇺🇸 USA |